Document is current
Any future updates will be listed below
-
Authors
Shorter, John R. https://orcid.org/0000-0003-4732-5526
Pasman, Joëlle A.
Kurvits, Siim
Jangmo, Andreas
Naamanka, Joonas
Harder, Arvid
Hagen, Espen https://orcid.org/0000-0002-1321-5970
Kowalec, Kaarina https://orcid.org/0000-0003-3928-9879
Frilander, Nelli
Zetterberg, Richard
Meijsen, Joeri J. https://orcid.org/0000-0002-4161-2199
Gådin, Jesper R.
Bergstedt, Jacob https://orcid.org/0000-0002-9279-6936
Xiong, Ying https://orcid.org/0000-0001-7644-014X
Hägg, Sara https://orcid.org/0000-0002-2452-1500
Landén, Mikael https://orcid.org/0000-0002-4496-6451
Rück, Christian
Wallert, John https://orcid.org/0000-0002-1473-4916
Skalkidou, Alkistis https://orcid.org/0000-0002-4935-7532
Koch, Elise https://orcid.org/0000-0003-3727-4470
Akdeniz, Bayram C.
Frei, Oleksandr https://orcid.org/0000-0002-6427-2625
,
Hovatta, Iiris https://orcid.org/0000-0002-5990-7892
Reichborn-Kjennerud, Ted https://orcid.org/0000-0003-4653-0034
Werge, Thomas M. https://orcid.org/0000-0003-1829-0766
Sullivan, Patrick F. https://orcid.org/0000-0002-6619-873X
Andreassen, Ole A. https://orcid.org/0000-0002-4461-3568
Tesli, Martin
Lehto, Kelli
Buil, Alfonso https://orcid.org/0000-0002-3097-1014
- License Information
-
More Information
Article History
Received: 1 November 2024
Accepted: 6 October 2025
First Online: 13 November 2025
Competing interests
: P.F.S. was a paid adviser and shareholder for Neumora Therapeutics. O.A.A. has received speaker fees from Lundbeck, Janssen, Otsuka and Sunovion, and is a consultant to Cortechs.ai and Precision Health. I.H. has received speaker honoraria from Lundbeck and Otsuka. The other authors declare no competing interests.
